Theiler's virus, a murine picornavirus, causes a persistent infection of the central nervous system with chronic inflammation and primary demyelination. We examined the nature of infected cells at different times postinoculation (p.i.) with a combined immunocytochemistry-in situ hybridization assay. The virus was found in the gray matter of the brain, mostly in neurons, during the first week p.i. During the following weeks, the virus was present in the spinal cord, first in the gray and white matter, then exclusively in the white matter. Approximately 10% of infected cells were astrocytes at any time during the study. Infected oligodendrocytes were first noticed on day 14 p.i. and amounted to approximately 6% of infected cells. The number of infected macrophages increased with time and reached a plateau by day 21 p.i., when at least 45% of infected cells were macrophages. The role of blood-borne macrophages during infection was studied by depleting them with mannosylated liposomes containing dichloromethylene diphosphonate. The virus did not persist in the majority of the mice treated with liposomes. These mice showed only minimal mononuclear cell infiltration and no demyelination.
Theiler's virus is a murine picornavirus that causes a persistent infection of the central nervous system (CNS) accompanied by a demyelinating disease (21, 22) whose histopathological lesions closely resemble those of active plaques of multiple sclerosis (MS). Intracerebral inoculation with Theiler's virus is followed by an acute encephalitis during which the virus is found mainly in the gray matter of brain. In some inbred strains of mice, the infection is not cleared and the animals become persistently infected. During this chronic infection, the virus is no longer found in the gray matter. Instead, it is present in a number of lesions disseminated throughout the white matter of the spinal cord. These lesions consist of perivascular infiltration of mononuclear cells, diffuse parenchymal inflammation, and myelin destruction with conservation of the axons.
A number of experimental results suggest that demyelination is, at least in part, immune mediated. Histological studies show the presence in the lesions of macrophages, B lymphocytes, and CD4 ϩ and CD8 ϩ T lymphocytes (7, 20) . Immunosuppressive treatments, e.g., with cyclophosphamide or with anti-Ia or anti-CD4 antibodies, reduce the extent of inflammation and prevent demyelination (23, 24, 31) . Moreover, it has been shown that a delayed-type hypersensitivity response against the virus, mediated by CD4 ϩ T cells, correlates with the development of chronic demyelination (10) . On the contrary, CD8 ϩ T cells, which are necessary for clearance of the infection in mouse strains genetically resistant to the persistent infection, are not major effectors of the demyelinating process (13) .
Although the immune system plays an important role in myelin destruction, viral persistence in the CNS is necessary for demyelination (10) . Thus, the mechanism of viral persistence is a central question of pathogenesis. In this context, the nature of the cells in which the virus persists is an important issue that has not been satisfactorily solved, although several papers have been published on the subject. By use of various immunohistological and in situ hybridization techniques, viral RNA and antigens have been detected in oligodendrocytes, astrocytes, and macrophages (1, 5, 19) . Recently, Lipton et al. demonstrated that the predominant viral burden resides in macrophages present in the lesions of the spinal cord but not in oligodendrocytes (25) . It should be noted that in most of these studies the CNS was examined at one time point only, usually a late one, in the course of this chronic disease. Furthermore, these studies were only descriptive and did not address the role played by particular target cells in viral persistence. We reassessed the nature of infected cells in a time course study, using well-characterized cell markers for astrocytes (GFAP), oligodendrocytes (PLP), and blood-borne macrophages and microglial cells (F4/80). We observed that the number of infected F4/80-positive cells increases with time, particularly in the white matter of the spinal cord where the virus is detected, whereas the number of infected cells of other lineages remains stable or decreases. Furthermore, we showed that blood-borne macrophages are critical in the establishment and maintenance of the persistent infection, since their specific depletion with liposomes results in clearance of the virus.
Four-week-old female SJL/J mice were obtained from Janvier, Le Genest-St-Isle, France. Mice were inoculated intracranially with 10 4 PFU of the DA strain of Theiler's virus. Mannosylated liposomes (PCMAN-liposomes) were prepared as previously described (17) . Briefly, 70.9 mg of phosphatidylcholine and 10.8 mg of cholesterol were dissolved in 8 ml of chloroform and added to 3.6 mg of p-aminophenyl-␣-Dmannopyranoside (Sigma Chemical Co., St. Louis, Mo.) dissolved in 2 ml of methanol. The mixture was dried under vacuum on a rotary evaporator until it formed a film. The molar ratio of phosphatidylcholine/cholesterol/mannoside (7:2:1) was chosen according to the method of Umezawa and Eto (29) . The total amount of lipids was 140 mol. The dried lipid film was dissolved in chloroform and dried once again before the aqueous phase, with dichloromethylene diphosphonate (Cl2MDP) (a gift of Boehringer Mannheim, Mannheim, Germany), was added. Liposomes were sonicated for 3 min at 20ЊC and 50 Hz, centrifuged (100,000 ϫ g), and finally resuspended in 4 ml of phosphate-buffered saline (PBS).
To measure the amount of viral RNA in the CNS, mice were perfused with PBS and their brains or spinal cords were immediately removed. Total RNA was extracted by the procedure of Chirgwin et al. (9) and was quantified by spectrophotometry. Series of fivefold dilutions of total RNA, starting from 10 g, were dotted onto Hybond C-extra filters (Amersham) according to the manufacturer's recommendations. The dot blots were hybridized overnight in 0.5 M sodium phosphate (pH 7.4)-7% sodium dodecyl sulfate at 65ЊC with 10 6 cpm of a virus-specific, random-primed, 32 P-labelled cDNA probe (specific activity, between 10 7 and 10 8 cpm/g). The filters were washed three times for 15 min each time at 65ЊC in 40 mM sodium phosphate (pH 7.4)-1% sodium dodecyl sulfate and exposed for 5 h in a phosphorimager or overnight at Ϫ80ЊC against an X-ray film.
Viral antigens were detected in the CNS by immunocytochemistry performed on serial coronal sections of brain and longitudinal sections of the entire spinal cord. Mice were perfused with PBS followed by 4% paraformaldehyde in PBS. The brain and spinal cord were dissected, cut into tissue blocks, and embedded in paraffin. The detection of viral antigens in 7-m-thick sections was performed as described previously, by using a primary rabbit anticapsid polyclonal serum, a secondary biotinylated goat anti-rabbit immunoglobulin, and the ABC peroxidase detection system (Vector Laboratories) (3). The sections were counterstained with hematoxylin. To evaluate demyelination, mice were perfused with PBS followed by 4% paraformaldehyde-1% glutaraldehyde in PBS. The spinal cord was dissected and cut into tissue blocks, which were embedded in Epon. One-micrometer-thick transverse sections were cut and stained with toluidine blue.
The combined immunocytochemistry-in situ hybridization assay has been described in detail elsewhere (4) . Briefly, an immunoperoxidase assay with diaminobenzidine as the substrate was used first, to detect the antigen of interest. Heparin was included in the reagents to inhibit RNase activities. The slides were then acetylated, to prevent nonspecific binding of the radioactive probe to the diaminobenzidine precipitate, and hybridized in situ with a 35 S-labelled cRNA probe. After development, the sections were counterstained with hematoxylin. The reagents used for the immunoperoxidase step of the assay were as follows. To identify astrocytes, we used an anti-GFAP rabbit serum (Dakopatts) diluted 1/500, followed by biotinylated anti-rabbit immunoglobulins (Vector Laboratories) diluted 1/200 and an avidin-biotin complex (ABC; Vector Laboratories). To identify macrophages and microglial cells, we used a rabbit polyclonal antibody against the F4/80 marker (18) (kindly provided by H. Perry) diluted 1/4,000, followed by a biotinylated anti-rabbit immunoglobulin (Vector Laboratories) diluted 1/200 and the ABC reagent (Vector Laboratories) with imidazole enhancement. To detect Theiler's virus antigens, we used a 1/300 dilution of a rabbit hyperimmune anticapsid serum which has been described previously (1), followed by biotinylated anti-rabbit immunoglobulins (Vector Laboratories) diluted 1/200 and an avidin-biotin complex (ABC; Vector Laboratories). The probes used for the in situ hybridization step were cRNA labelled with 35 S by in vitro transcription of a linearized recombinant plasmid. In vitro transcription was performed by standard procedures with 35 S-UTP (1,200 Ci/mmol) as a precursor. Two different plasmids were used. To detect viral RNA, we used a plasmid which contains a 280-bp insert corresponding to nucleotides 1 to 280 of the genome of Theiler's virus. To identify oligodendrocytes, we used plasmid pLH-116, which consists of the entire coding region of mouse proteolipid protein (PLP) cDNA cloned in pGEM3 vector (a gift of L. Hudson, National Institutes of Health, Bethesda, Md.). In situ hybridization with these probes was performed as described elsewhere, including RNase treatment after hybridization to reduce background (4) .
Phenotypes of infected cells in the CNS. We used the assay described above to examine the types of cells which are infected in the CNS at different times postinoculation (p.i.). Groups of three SJL/J mice inoculated with Theiler's virus were sacrificed on days 8, 11, 14, 21, and 45 p.i. For each mouse, three to six coronal sections of brain and two to four longitudinal sections of the entire spinal cord were examined. Every infected cell encountered was scored positive or negative for the corresponding cell marker. The majority of infected cells (65 to 75%, depending on the slide) could be unambiguously identified. The phenotypes of the infected cells present in the CNS at different times p.i. are shown in Fig. 1 .
One week p.i., the virus was present only in the gray matter of the brain. The majority of the infected cells were neurons, as identified by morphology. Astrocytes and macrophages each accounted for 10% of the infected cells. No infected oligodendrocytes were observed. A change in the infection pattern was observed between the 1st and 2nd weeks p.i. The number of infected cells in the brain declined drastically, and the virusspecific signal shifted to the spinal cord, where it was exclusively localized by day 14 p.i. In the spinal cord, the virus was found in both the gray and the white matter on day 11 p.i., and by day 14 p.i. it had practically disappeared from the gray matter and was located almost exclusively in the white matter. Together with this shift from the gray to the white matter, The phenotypes of infected cells were determined by a combined immunohistochemistry-in situ hybridization assay. The cell markers used were F4/80 for macrophages and microglial cells (Ç), GFAP for astrocytes (E), and PLP mRNA for oligodendrocytes (X). Infected cells were identified in the same section by in situ hybridization or immunocytochemistry. Groups of two to three mice were studied for each time point. For each mouse, two to five slides were studied for each cell type marker. Each slide contained three coronal sections of brain and one longitudinal section of the entire spinal cord. Each slide was entirely scanned under the microscope, and every infected cell encountered was scored positive or negative for the corresponding cell type marker. The graph shows the average percentage of infected cells belonging to each category.
there was an increase in the number of infected macrophages, which reached a plateau by day 21 p.i. (Fig. 1) . At that time, 44% of the infected cells were identified as macrophages by the anti-F4/80 serum. This percentage remained the same until day 45 p.i. Since 25 to 35% of the infected cells could not be identified, it is likely that the macrophages represented an even larger percentage of these cells. In contrast, during the same period, the percentage of infected cells identified as astrocytes remained stable (approximately 10%). Infected oligodendrocytes appeared by day 14 p.i. only (6% of infected cells) and remained at that level until day 45 p.i. These results show that the majority of infected cells during the chronic phase of the infection are macrophages.
Effect of in vivo depletion of macrophages. To study the role of macrophages in the chronic disease, we used mannosylated liposomes containing Cl2MDP to selectively eliminate this cell population. When injected intravenously, these liposomes are phagocytized by macrophages, and the Cl2MDP is released into the cells and kills them (30) . Incorporation of a mannosylated ligand in the lipid layers of the liposomes may lead to a more efficient binding to macrophages which express the mannose receptor (12, 14, 27) . SJL/J mice were infected intracerebrally, then injected intravenously with 200 l of liposomes on days 7 (when bloodborne macrophages begin to infiltrate the CNS), 11, 15, and 19 p.i. Control mice received no treatment. Animals were sacrificed on day 21 p.i., and the spinal cords were dissected and processed for viral RNA quantification. The amount of viral RNA in the spinal cord was measured by using a dot blot hybridization assay and serial dilutions of the RNA. A total of 16 liposome-treated and 13 untreated control mice were studied in two separate experiments. No viral RNA could be detected in 70% of treated mice, whereas all control mice were persistently infected. A representative dot blot obtained in one experiment is shown in Fig. 2 .
Other mice were infected, left untreated or treated with liposomes according to the protocol described above, and sacrificed on day 21 p.i. for histological studies. The spleen was dissected, embedded in paraffin, and examined after immunohistological staining to check for depletion of peripheral macrophages. For liposome-treated mice, the spleen was considerably reduced in size and contained only very few F4/80 ϩ cells. The spinal cord was examined to study the effect of macrophage depletion on CNS inflammation and demyelination. As shown in Fig. 3 , typical lesions of inflammation and demyelination were observed in all the control mice. Several infected cells, identified with a virus-specific serum, were present in these lesions. The macrophage-specific anti-F4/80 antibody stained large numbers of cells throughout the tissue and many of the cells infiltrating the lesions (Fig. 3B) . In contrast, minimal mononuclear cell infiltration, only a few F4/80 ϩ cells, and very few infected cells could be observed in the parenchyma for four of six liposome-treated mice (Fig. 3A) . In the other two liposome-treated mice, the number of macrophages was roughly the same as in the untreated animals, showing that macrophage depletion was not successful in the CNS for all the mice. Spinal cord segments from three liposome-treated mice and two control mice were embedded in Epon to prepare semithin sections. Whereas typical demyelinating lesions were found in the control animals (Fig. 3D) , no demyelination was observed in a total of 21 segments examined from the three treated mice (Fig. 3C) . Therefore, these experiments confirmed that macrophages are the main target cells during the persistent phase of the infection. They also show that these cells play an important role in demyelination.
The results of the present study assign an important role to macrophages in the persistence of Theiler's virus infection and in the accompanying chronic CNS disease. Several studies have examined the nature of CNS cells infected by Theiler's virus already, particularly during the late white matter disease (1, 5, 19) . The results were not always consistent, in particular regarding the proportions of the various glial cells among infected cells. In the present study we reexamined this question using unambiguous cell markers. Astrocytes were identified by the presence of GFAP, a faithful marker for these cells (11) . Oligodendrocytes were identified by the presence of PLP mRNA, which is expressed only in oligodendrocytes (28) . Furthermore, this mRNA is confined to the perinuclear cytoplasm. Finally, the expression of the F4/80 antigen in the CNS has been studied extensively. This cell surface marker is present exclusively on cells of the macrophage-microglial cell lineage (18) . It should be noted at this point that neither F4/80 nor any of the other macrophage markers discriminates between invading blood-borne macrophages and activated resident microglial cells.
Our data confirm that all the cell types that have been described previously as targets for Theiler's virus persistent infection, astrocytes, oligodendrocytes, and macrophages, are indeed infected. Whereas oligodendrocytes and astrocytes remain the minority of the infected cells throughout the infection, macrophages become the majority by day 21 p.i. At that time, approximately 50% of the infected cells are macrophages. The discrepancy with our previous data, which indicated that oligodendrocytes were the main target (1), is most likely due to the fact that the oligodendrocyte marker used at the time (carbonic anhydrase II) has now been shown to stain other cell types as well (6) . After 20 days of infection, when the virus was confined to the white matter of spinal cord, 25 to 35% of infected cells could not be identified, mainly due to crowding of nuclei and superimposition of cells, which made the attribution of autoradiographic grains to a particular cell impossible. These cells had the same spatial distribution as those that were identified. Of course, since we did not use lymphocyte markers, we cannot formally exclude the possibility that some of the infected cells that were not identified were inflammatory B or T cells.
We studied the role of macrophages during infection by specifically depleting infected mice of macrophages using the PCMAN-liposome system. We found that viral RNA and viral antigens were almost completely eliminated from the majority of treated mice. The fact that the treatment failed to eliminate the virus in some of them was most likely due to technical problems during the intravenous injections of liposomes, leading to a low level of depletion, since histological studies showed a correlation between depletion of the F4/80 ϩ cells and absence of viral antigen. Thus, this result confirms that most of the viral burden is in the macrophages during persistent infection. It suggests, but does not formally prove, that macrophages play a central role in viral persistence. Treatment with PCMAN-liposomes depletes mainly bloodderived macrophages infiltrating the CNS (2). Although resting microglial cells are not depleted by this treatment, we cannot rule out the possibility that they play an important role in viral persistence. They could be a main source of infected cells since, once activated, they are indistinguishable from macrophages when the F4/80 marker is used.
The mechanism of the demyelination caused by Theiler's virus is not fully understood, although we know that it requires persistence of the infection in the white matter (8) . Viral persistence may have several consequences. First, the continuous infection of oligodendrocytes could bring about demyelination, either through lysis of the cell or because of impaired myelin protein synthesis without lysis (26) . Second, persistent viral antigen expression may result in continuous activation of T cells and macrophages responsible for an immune-mediated pathology. As a matter of fact, virus-specific CD4 ϩ T cells, responsible for a delayed-type hypersensitivity reaction, have been characterized and implicated in demyelination (10, 15, 16) . It has been suggested that these cells could recruit and activate macrophages at the site of infection and that the protracted presence of activated macrophages in the white matter could result in nonspecific, "bystander" myelin destruction. The effect of liposome treatment on demyelination could be due both to the reduction of viral antigen expression and to the elimination of the effector cells.
In conclusion, blood-borne macrophages may be playing several roles in the pathogenesis of this disease. (i) As shown in particular in the present work, they are the main reservoir of virus in the white matter. (ii) By activating resident microglial cells, they may enlarge further the population of target cells. (iii) Finally, they may be the main effector cells for demyelination.
